bdp 12 has been researched along with idra 21 in 2 studies
| Studies (bdp 12) | Trials (bdp 12) | Recent Studies (post-2010) (bdp 12) | Studies (idra 21) | Trials (idra 21) | Recent Studies (post-2010) (idra 21) |
|---|---|---|---|---|---|
| 62 | 7 | 14 | 24 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boxall, AR; Nagarajan, N; Quast, C; Rosenmund, C; Shahid, M | 1 |
| Black, MD | 1 |
1 review(s) available for bdp 12 and idra 21
| Article | Year |
|---|---|
Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.
Topics: Alzheimer Disease; Animals; Benzothiadiazines; Cognition; Dioxoles; Humans; Long-Term Potentiation; Memory; Neuroprotective Agents; Piperidines; Protein Subunits; Receptors, AMPA; Schizophrenia | 2005 |
1 other study(ies) available for bdp 12 and idra 21
| Article | Year |
|---|---|
Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546.
Topics: Allosteric Regulation; Benzothiadiazines; Cell Line; Dioxoles; Excitatory Amino Acid Agonists; Glutamic Acid; Humans; Patch-Clamp Techniques; Piperidines; Receptors, AMPA; Synaptic Transmission | 2001 |